AI assistant
Sending…
ANI PHARMACEUTICALS INC — Director's Dealing 2013
Aug 22, 2013
31676_dirs_2013-08-22_449073ee-3835-4e32-b1d9-976e50a703e4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2013-08-20
Reporting Person: MANGANO ROSS J (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-08-20 | Common stock, par value $0.0001 per share | P | 10000 | $7.4659 | Acquired | 18550 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common stock, par value $0.0001 per share | 50957 | Indirect |
| Common stock, par value $0.0001 per share | 833 | Indirect |
| Common stock, par value $0.0001 per share | 4604 | Direct |
Footnotes
F1: Held by various trusts, of which the Reporting Person is the trustee, for the benefit of family members.
F2: Held by JO & Co., of which the Reporting Person is a partner.
F3: Held by Oliver & Co., of which the Reporting Person is the trustee.
More from ANI PHARMACEUTICALS INC
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 8
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Regulatory Filings
2026
Mar 3